Watch PBYI. Know when insiders buy.
One email the day a filing lands. Free.
PBYI
PUMA BIOTECHNOLOGY, INC.
10.44
−0.10 −0.95%
USD · close Oct 30
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
37
FLAG · insiders 29, shorts 44
Insiders, 90 days
−$612K
net selling · 0 buys, 2 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $538.9MP/E 20.1DIV YIELD —FCF YIELD 7.64%REV TTM $231.2M −2.9%NET INCOME $26.7M −44.9%NET CASH $25.2M52W 4.73 – 11.26SEC XBRL · TTM TO Invalid Date
Who holds it
None of the 15 tracked funds disclose PBYI in their latest 13F. The funds we follow.
13F filings cover US-listed holdings and arrive up to 45 days after quarter end, so positions may have changed since.
Stakes of 5% or more
Alan H. Auerbach16.0%
“The information set forth or incorporated in Item 3 above is incorporated herein by reference. From time to time, Mr. Auerbach may acquire beneficial ownership of additional shares of Common Stock or other securities of the Issuer by purchase, as compensation from the Issuer, or otherwise, including…”
A 13D means the holder crossed 5% with intent beyond passive ownership and had to state a purpose; a 13G is the passive version. Every new 13D on tracked companies.